It is my pleasure to welcome you to the 1st Middle East Cardiovascular Pharmacotherapy Forum to be held on 14th October 2023 at Jumeirah Creekside hotel, Dubai.
In this emerging era of increased heart disease, particularly in the Middle East region, we take this opportunity to discuss the latest advancement in cardiovascular pharmacotherapy and to have our forum as a “Call for Action” for implementing guideline directed medical therapy in our region.
This inaugural version of the forum will aim to bring together prominent individuals in the field both in the region and internationally and will be inclusive of all cardiovascular pharmacotherapy practice settings.
We look forward to welcoming you in Dubai. With your important contribution we aim to have MECVPT forum as the primary scientific gathering of cardiovascular pharmacotherapy specialists in the region and to become an awaited yearly event.
Dr. Bassam Atallah
Pharm.D., M.S., BCPS-AQ Cardiology, FHFSA Chairman, MECVPT 2023 Clinical Associate Professor Cleveland Clinic Lerner College of Medicine of Case Western Reserve University Heart and Vascular Institute Pharmacotherapy Specialist Cleveland Clinic Abu Dhabi United Arab Emirates
O
Our Faculty
*Faculty is arranged Alphabetically
Ahmad El Ouweini
Critical Care Clinical Pharmacist and Clinical Lecturer
Gulf Medical University
United Arab Emirates
Ahmed Aljedai
Founding President Saudi Society of Clinical Pharmacy (SSCP)
Assistant Deputy Minister for Therapeutic Affairs
Ministry of Health, Riyadh
Saudi Arabia
Ahmed Aldemerdash Chairman, Pharmacy Scientific Council Saudi Commission for Health Specialties (SCFHS) Saudi Arabia
Amnah Mukhtar
Head Medication Safety/Clinical Pharmacy Support Services
King Faisal Specialist Hospital and Research Center, Jeddah
Saudi Arabia
Antoine Cherfan
Senior Director Pharmacotherapy Services
Cleveland Clinic Abu Dhabi
United Arab Emirates
Bassam Atallah
Senior Pharmacotherapy Specialist
Department of Pharmacy Services
Cleveland Clinic Abu Dhabi
United Arab Emirates
Bassam R. Ali
Professor of Genomic Medicine
College of Medicine and Health Sciences United Arab Emirates University
United Arab Emirates
Craig James Beavers
Vice President, Operations Executive/Clinical Leader for Cardiovascular, Surgical Services, Pharmacy, Oncology/Radiology, Facilities, Environmental Services, Business Development, Food and Nutrition Services Baptist Health Paducah
United States
Emad El Kholy
Cardiology/Critical care Pharmacist
King Abdullah Medical City
Saudi Arabia
Emadeldin Hosney Eldaly
Clinical Pharmacist / Cardiology and internal medicine
Sheikh Khalifa medical city (SKMC)
United Arab Emirates
Fakhr Z. AlAyoubi
President, Saudi Cardio Clinical Pharmacy Group at the Saudi Heart Association
Saudi Heart Society
Saudi Arabia
Hisham Badreldin
Associate Professor Consultant Cardiovascular Pharmacotherapy Specialist
Department of Pharmacy Practice, College of Pharmacy
King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS)
King Abdullah International Medical Research Center (KAIMRC)
King Abdulaziz Medical City (KAMC)
Ministry of National Guard Health Affairs (MNGHA)
Riyadh Saudi Arabia
Jamila Alaryani
PGY1 Pharmacy Resident
Cleveland Clinic Abu Dhabi
United Arab Emirates
Kazuhiko Kido
Clinical Associate Professor
Clinical Pharmacy West Virginia University (WVU) School of Pharmacy
United States
Mohamad Shara
Visiting Associate Professor of Clinical Pharmacy
University of Sharjah, College of pharmacy
United Arab Emirates
Nibal Chamoun
Clinical Associate Professor and Assistant Dean of Experiential Education and
Residency Program
Lebanese American University (LAU) School of Pharmacy (SOP)
Lebanon
Rahmeh Qandil
Clinical Tutor
University of Sharjah, College of Pharmacy
United Arab Emirates
Salahdein Mohammed AbuRuz
Director of PharmD and PhD programs, Professor of Clinical Pharmacy and Pharmacotherapy/ Department of Pharmacology and Therapeutics,
United Arab Emirate University
United Arab Emirates
Saad Sultan Executive Director of Pharmacy Services
Cleveland Clinic Abu Dhabi
United Arab Emirates
Said Nabil
International Relations Committee
Heart Failure Society of America (HFSA)
Researcher
Cleveland Clinic Abu Dhabi
United Arab Emirates
Salma Alzaabi
Clinical staff Pharmacist
Cleveland Clinic Abu Dhabi United Arab Emirates
Sana Hasan Associate Professor of Clinical Pharmacy & Coordinator of the MSc in Clinical Pharmacy Program
Ajman University College of Pharmacy and Health Sciences
United Arab Emirates
Seeba Zachariah
Clinical Assistant Professor, Department of Pharmacy Practice, College of Pharmacy, Gulf Medical University
United Arab Emirates
Ziad Sadik
Senior Pharmacotherapy Specialist: Cardiology and Internal Medicine Cleveland Clinic Abu Dhabi
United Arab Emirates
A
Agenda
Session 1
Chairperson : ABC
10:15 - 10:45 AM
Dr. Mohamed Salah
Topic 1
10:45 - 11:15 AM
Dr. Mohamed Salah
Topic 2
11:15 - 11:45 AM
Dr. Mohamed Salah
Topic 3
11:45 - 12:00 PM
Topic 4
12:00 - 12:15 PM
Discussion
12:15 - 02:15 PM
Prayer & Lunch
Session 2
Chairperson : Prof. ABC
02:15 - 02:45 PM
Dr. Mohamed Salah
Topic 1
02:45 - 03:15 PM
Dr. Mohamed Salah
Topic 2
03:45 - 04:00 PM
Discussion
04:00 - 04:15 PM
Coffee Break
Session 3
Chairperson : Dr. ABC
04:15 - 04:45 PM
Dr. Mohamed Salah
Topic 1
04:45 - 05:15 PM
Dr. Mohamed Salah
Topic 2
05:15 - 05:45 PM
Dr. Mohamed Salah
Topic 3
05:45 - 06:00 PM
Discussion
Coming Soon
Click on the session name for more details about the session
cURL Error #:Could not resolve host: events.mme-conferences.com
O
Our Location
Jumeirah Creekside Hotel, Dubai
S
Silver Sponsors
Novartis is reimagining medicine to improve and extend people’s lives. We deliver high-value medicines that alleviate society’s greatest disease burdens through technology leadership in R&D and novel access approaches. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. About 103,000 people of more than 140 nationalities work together to bring Novartis products to nearly 800 million people around the world. Find out more at https://www.novartis.com
Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. More than 52,000 employees serve over 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. Learn more at www.boehringer-ingelheim.com
A
Associate Sponsors
C
Contact Us
Meeting Minds Experts: Office 508 & 509, DSO Tower Building, Dubai Studio City